Name of this trial: TRIDENT What type of cancer is this for? Pancreatic Adenocarcinoma Who is this trial for? Subjects With Previously Untreated Metastatic Pancreatic Adenocarcinoma What biomarkers are involved? N/A What is the National Clinical Trial #? NCT07259317; https://clinicaltrials.gov/study/NCT07259317 Brief summary of this trial: Phase 2, single arm trial of Relacorilant in combination with
Phone: (800) 411-7999
